A stem cell facial is an emerging aesthetic treatment attracting interest from people looking to improve skin texture, signs of aging, and acne scarring. Unlike a conventional facial built around cleansing and hydration, these treatments may use cell-derived materials as part of a regenerative approach to skin repair. Whether it actually works, and for how long, depends on the specific treatment, the materials used, and individual skin condition.

How Does a Stem Cell Facial Work?

Most treatments marketed as a stem cell facial do not actually use live cells. Instead, they use microscopic cellular messengers, such as exosomes and conditioned media, harvested from cell cultures. These messengers may send signals that prompt skin cells (fibroblasts) to produce collagen, supporting hydration and overall skin quality, though the effect varies between individuals. This differs fundamentally from a conventional facial, which focuses on cleansing, exfoliation, and short-term hydration rather than any biological signaling process.

These materials are typically applied topically or introduced through microneedling or radiofrequency devices that create temporary micro-channels in the skin, allowing better penetration. The treatment is generally delivered in a series of sessions rather than as a single visit, with a consultation beforehand to assess skin condition and confirm the approach is appropriate.

Potential Benefits of a Stem Cell Facial

Clinical research points to benefits across three areas, though results vary by individual and the overall evidence base is still developing:

• Anti-aging (fine lines and wrinkles): A split-face trial comparing adipose exosomes with platelet-rich plasma applied over three radiofrequency microneedling sessions, one treatment per side of the face, found both equally improved wrinkling, discoloration, redness, texture, and overall appearance in mild to moderate photoaging. Skin biopsies taken six months later confirmed increased collagen I and glycosaminoglycans, the components that give skin structure and moisture retention, with no meaningful difference between the two treatments.
• Skin elasticity and firmness: A 12-week randomized trial of 28 participants compared an adipose exosome solution plus microneedling against saline plus microneedling on the opposite side of the face, across three sessions. Using objective measuring devices rather than visual judgment alone, it recorded greater improvement in elasticity, wrinkles, and pigmentation on the exosome-treated side, with a significantly higher overall aesthetic improvement score.
• Hydration: The same 28-participant trial measured skin moisture with a dedicated hydration device and found greater improvement on the exosome-treated side than the control side. 

Outcomes depend on skin condition, treatment protocol, and aftercare. While findings are encouraging, larger standardized trials are still needed.

How Long Does a Stem Cell Facial Last

Results typically develop gradually, with follow-up needed to assess progress. How long improvements last depends on the treatment protocol used, ongoing skincare, sun protection, and individual skin response, so no single, fixed timeline applies to every patient.

Is a Stem Cell Facial Safe?

Safety depends on the exact procedure, materials, and provider. A “stem cell facial” may cover different technologies. Therefore, disclosing relevant medical and skin history and discussing risks with a qualified provider before treatment are highly recommended.

Commonly reported, temporary effects:

• Redness or flushing at the treatment site, usually settling within a few days
• Mild swelling or a feeling of tightness in the treated area
• Tenderness or sensitivity to touch shortly after a session

Effects more likely with device-assisted delivery (microneedling or radiofrequency):

• Pinpoint bleeding or small scabs where micro-channels were created
• Temporary dryness or flaking as the skin recovers
• A short period of increased sensitivity to sun, making sun protection important

Any treatment carries some risk, and reactions can vary with the specific materials used and an individual’s skin. Follow up with your doctor if you’re experiencing spreading redness, persistent swelling, or unusual pain.

What to Expect During a Stem Cell Face Treatment in Bangkok

• Consultation and skin assessment: Discuss goals, medical history, and any previous treatments, since this information shapes whether a regenerative approach is suitable
• Treatment explanation: The clinician explains the specific materials and delivery method being used before the session begins
• Aftercare and downtime: Ranges from minimal for topical application to a few days of redness if combined with microneedling or radiofrequency
• Follow-up assessment: Tracks how the skin is responding over time

Stem Cell Facial Treatment at Vega Dermatology & Wound Care Unit

A stem cell facial is a promising option for patients looking to improve skin texture, fine lines, and acne scarring, especially when used as part of a broader treatment plan.

At our clinic, regenerative skin support is planned around an individual skin assessment, drawing on research from the Vega Stem Cell Clinic. Our regenerative protocols currently support three clinical areas:

• Chronic wounds and diabetic ulcers: Growth factor media, delivered as VEGF and PDGF signaling rather than live cell implantation, may help support tissue repair and circulation in wounds that have stalled under conventional care.
• Scars, including keloid, acne, and post-surgical: Our stem cell therapy for acne scars in Bangkok may help support collagen remodeling and tissue quality as part of a staged scar management plan with microneedling, laser, or biostimulators.
• Hair and scalp regeneration: Regenerative treatments may help support the follicular environment and scalp health and can complement transplantation and preservation procedures through Follicular Signaling Enhancement (FSE) offered at Vega.

Care is overseen by Dr. Ekkaparb Charoensuk, an integrative and regenerative medicine physician with more than 15 years of clinical experience. Book a consultation with our clinical team at Vega Dermatology & Wound Care Unit for a skin assessment to discuss whether a regenerative approach is appropriate for your skin.

References:

• Adipose Mesenchymal Stem Cell-Derived Exosomes Versus Platelet-Rich Plasma Treatment for Photoaged Facial Skin: An Investigator-Blinded, Split-Face, Non-Inferiority Trial. Retrieved August 18, 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12104007/
• Efficacy of Combined Treatment with Human Adipose Tissue Stem Cell-Derived Exosome-Containing Solution and Microneedling for Facial Skin Aging: A 12-Week Prospective, Randomized, Split-Face Study. Retrieved August 18, 2026, from https://pubmed.ncbi.nlm.nih.gov/37377400/
• Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies. Retrieved August 18, 2026, from https://www.cureus.com/articles/467420-efficacy-of-exosome-based-therapies-for-skin-rejuvenation-a-systematic-review-of-human-studies
• The Efficacy of MSC-Derived Exosome-Based Therapies in Treating Scars, Aging and Hyperpigmentation: A Systematic Review of Human Clinical Outcomes. Retrieved August 18, 2026, from https://www.mdpi.com/2571-841X/8/4/268

Thailand has become one of the most popular destinations for regenerative treatments, and cell-based therapies are a growing part of that picture. Popularity, however, does not automatically mean safety. The quality gap between providers is wide, and the standards that shape patient outcomes vary considerably from clinic to clinic.

What Is Stem Cell Therapy

Stem cells are cells with the ability to develop into different types of specialized cells, which is what sets them apart from ordinary body cells with fixed functions. Stem cell therapy uses these properties in medicine to support tissue repair or influence how surrounding cells behave. The term covers a wide range of applications, from established treatments for blood cancers to newer aesthetic and orthopedic uses, and evidence levels vary significantly across those applications.

Why People Choose Thailand for Stem Cell Therapy

Thailand’s medical infrastructure, lower treatment costs compared to Western countries, and established reputation for medical tourism make it a common destination for patients exploring regenerative options. For patients considering stem cell therapy in Bangkok and other major cities, many hospitals and private clinics operate at internationally accredited standards, with English-speaking physicians and dedicated support for international patients. The city’s medical tourism infrastructure also includes patient coordinators and structured follow-up options for patients travelling from abroad.

The range in quality is significant, however. Whether Thailand is good for stem cell therapy  depends almost entirely on which provider a patient chooses.

What Are the Actual Risks

No medical treatment is entirely risk-free, and cell-based therapies are no exception. If you are wondering are there any risks of using stem cells, the answer is yes, in every protocol. The most commonly reported concerns include:

• Infection at the injection or treatment site
• Unwanted immune reactions to administered cells
• Unpredictable cell behavior, meaning that cells may not integrate, activate, or perform as the protocol intends
• Delayed or reduced response when patient suitability has not been properly assessed

Risk increases significantly when clinical standards are inadequate. This includes uncontrolled cell sourcing and processing, treatment delivered outside of standardized protocols, and skipping suitability assessment before therapy begins. Most cell-based therapies for aesthetic or anti-aging purposes have not received formal regulatory approval from major bodies such as the US FDA. This does not mean every treatment is unsafe, but it does mean the burden of evaluating safety sits more heavily with the patient and the clinic they choose. Ultimately, whether stem cell therapy is safe in Thailand comes down to the specific clinic, not the country.

How to Evaluate a Provider in Thailand

Not all clinics offering cell-based therapies operate to the same standard. A few practical checks help separate proper regenerative practice from marketing-led facilities:

• The clinic clearly explains what cell source is being used, where it comes from, and how it is processed
• Treatment is supervised by a licensed physician, not delegated entirely to non-medical staff
• The provider discusses realistic outcomes and potential risks openly, not only the benefits
• Patient records, follow-up protocols, and proper informed consent are standard practice
• A structured follow-up schedule is part of the plan from the start, not an afterthought

Warning signs include clinics that guarantee specific results, promote treatments as a cure-all for unrelated conditions, or fail to provide clear answers about cell sourcing and compliance. A facility unwilling to discuss why a particular patient might not be a candidate reveals a great deal about its internal standards. Transparency on these points is not a marketing preference, but the essential foundation for informed consent.

Beyond these initial conversations, verifying a clinic’s medical license and the credentials of its treating physicians is a crucial step before booking. Understanding what standard clinical practice looks like ultimately equips patients to ask the right questions and evaluate potential providers with confidence.

What Treatment Actually Involves

Treatment protocols vary. Some involve harvesting cells from the patient’s own tissue, processing them under sterile conditions, and reintroducing them to the target area. Others use donor-sourced or cell-derived products such as growth factor preparations. Delivery methods range from injection to topical application combined with microneedling, depending on the protocol and the area being treated.

Recovery is typically mild for most protocols, with some redness, swelling, or tenderness at the treatment site that generally settles within the first few days. Visible results are not immediate. Most patients notice changes gradually over weeks to months, and some protocols require more than one session to complete a full course. The number of sessions depends on the protocol, the tissue being treated, and how the individual patient responds during early follow-up. Some protocols are delivered in a single session; others involve two or three sessions spaced weeks apart.

Not everyone is a suitable candidate. Age, existing medical conditions, current medications, immune status, and the specific condition being treated all influence whether a regenerative approach is appropriate. Certain autoimmune conditions, active infections, or specific medication regimens may rule out a given protocol until those factors are addressed or stabilized under medical care. In some cases, a course of pre-treatment blood work or specialist review is required before candidacy can be confirmed.

Regenerative Care Grounded in Clinical Standards

At Vega Dermatology & Wound Care Unit in Bangkok, cell-based therapies are offered within a broader practice that combines dermatology, wound care, and regenerative medicine. This means the treating team understands not just the protocol itself but the underlying tissue biology, healing dynamics, and skin or vascular conditions that shape how it performs on the individual patient.

Protocols at the Vega Stem Cell Clinic draw on this combined expertise, with treatment planning shaped by the individual case rather than a fixed menu. The approach centers on proper assessment, a transparent process, and an honest outcome discussion. Whether stem cell therapy is safe in Thailand for a given patient depends less on the country and more on choosing a clinic that treats these standards as the baseline.

Suitability for regenerative treatment is decided case by case. Book a consultation today with the clinical team at Vega Dermatology & Wound Care Unit to review yours.

References:

• A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions. Retrieved 26 August 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127222/ 
• Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials. Retrieved 26 August 2026, from https://pmc.ncbi.nlm.nih.gov/articles/PMC3485008/

A stem cell hair transplant is not what most patients expect. It describes a specific, still-investigational procedure rather than the umbrella term many patients assume covers everything from injections to surgery. Understanding what it actually is, and what it isn’t, matters when weighing hair restoration options.

Patients researching hair restoration often encounter the phrase without a clear sense of what it technically involves, how it differs from a standard transplant, or whether it’s something they can currently access. Here’s what a stem cell hair transplant actually is, what current evidence and regulatory status say about it, and where physician-led regenerative options fit for patients today.

What Is a Stem Cell Hair Transplant?

A stem cell hair transplant is an injection-based procedure. The approach involves a small tissue sample processed in a laboratory to isolate cells, which are then re-injected into thinning areas of the scalp. This is distinct from relocating existing follicles surgically.

A traditional hair transplant moves whole follicular units from a donor area (usually the back of the scalp) to areas of thinning. A stem cell hair treatment of this kind does not move follicles, but instead attempts to reactivate dormant or miniaturized follicles by injecting processed cell populations. The mechanism, the equipment, and the patient experience are all different.

Regulatory status is a real differentiator here, as the procedure is not FDA-approved for hair loss as of now. The FDA has specifically advised patients to confirm that any stem cell procedure is either FDA-approved or being studied under an Investigational New Drug application before proceeding.

Is a Stem Cell Hair Transplant Permanent?

The direct answer is no. Published pilot studies measure density gains over weeks to months, not permanence.

Here’s the general shape of the evidence: small Italian and South Korean pilot studies have reported density increases of roughly 25 to 30 percent, measured several months after treatment. However, these are early findings from small patient cohorts, not large randomized trials. Results vary by study and by patient, and clinics offering this procedure outside a formal trial setting cannot guarantee outcomes.

That is important context for anyone told the effect will “last a lifetime.” Unlike the timeline of approved hair transplant approaches, at the current state of research, stem cell hair regrowth from these protocols appears measurable but temporary for some patients, and long-term durability has not been established.

Stem Cell Hair Transplant vs. What Clinics Actually Offer

The literal live-cell-injection procedure described above is different from what many clinics, including Vega, currently provide under the broader banner of regenerative hair care. The public search term is often “stem cell hair transplant” or stem cell therapy for hair loss, but the delivery in practice is generally through concentrated bio-active signaling molecules rather than live-cell implantation.

This is an important distinction when comparing clinics, as a clinic offering “stem cell hair therapy” may be delivering any of several different underlying protocols. Ask what is actually being injected, how it was processed, and what regulatory status applies to the material used.

Hair Transplantation vs. Regenerative Follicle Support

Two established categories of care exist alongside investigational stem cell approaches.

Surgical hair transplantation, most commonly Follicular Unit Extraction (FUE), relocates healthy viable follicles from the donor area into thinning or bald zones. This works well for patients with adequate donor supply and defined areas of loss. A well-run hair transplantation clinic will assess donor quality and treatment goals before recommending FUE.

Non-surgical regenerative follicle support, including protocols like hair follicle regeneration Thailand clinics offer under the FSE (Follicular Signaling Enhancement) umbrella, works differently. It targets follicles that are thinning but not yet lost, and can be used as an adjunct to surgical transplantation to support graft take and treatment response. It does not replace surgery when follicles are already gone.

Who Might Consider Regenerative Hair Support

Regenerative hair support may fit patients with early to moderate thinning, limited donor supply, or prior transplant results that need improvement. It also fits patients who want to explore stem cell hair restoration options before considering surgery.

Trichoscopy-based assessment is the deciding factor rather than self-diagnosis. Scalp imaging allows a physician to see follicle density, miniaturization patterns, and scalp condition at a level the eye cannot. Regenerative protocols are suitable for both men and women following physician evaluation.

Vega’s Approach to Hair Restoration

At Vega Dermatology & Wound Care Unit in Bangkok, hair restoration is a physician-led program that combines FUE transplantation with Follicular Signaling Enhancement (FSE) and Hair & Scalp Regeneration under one medical team. The three approaches work together within one program.

Every treatment recommendation follows a structured trichoscopy-based assessment. With us, progress is tracked over 12 months with objective follow-up via a trichoscopy and photo comparison. Our program is led by Dr. Aritaj Aiumtrakul, an ISHRS-trained hair restoration and scalp specialist. English-speaking support is available throughout treatment for international patients, and our unit is part of the wider Vega Stem Cell Clinic regenerative-medicine group.

Choose an Evidence-Aware Path to Hair Restoration

A stem cell hair transplant, in the literal sense, is an investigational injection-based procedure that isn’t FDA-approved. Published studies show modest density gains rather than guaranteed or permanent results. Regenerative hair support offered in clinics today, including at Vega, generally works through bio-active secretome signaling and surgical FUE transplantation rather than live-cell implantation.

Vega Dermatology & Wound Care Unit’s hair program combines FUE transplantation, Follicular Signaling Enhancement, and Hair & Scalp Regeneration under the care of our hair restoration physicians, led by Dr. Aritaj Aiumtrakul with structured trichoscopy assessment and 12-month tracking. Choosing among approaches is a clinical decision that follows from a proper scalp assessment.

Book a consultation with our clinical team at Vega Dermatology & Wound Care Unit and explore your options for stem cell therapy for hair loss and hair follicle regeneration in Thailand today. With us as your hair transplantation clinic, a trichoscopy-based assessment can clarify which regenerative or surgical option, or combination, fits your pattern of thinning

References:

• Androgenetic Alopecia. Retrieved August 27, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK430924/ 
• Hair Loss. Retrieved August 27, 2026, from https://medlineplus.gov/hairloss.html 
• Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. Retrieved August 27, 2026, from https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes 
• Hair Transplantation. Retrieved August 27, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK547740/

Diabetic foot ulcers are persistent wounds that can be difficult to heal because diabetes impairs circulation, nerve function, and the immune response needed for tissue repair. Left unmanaged, they carry real risks, including infection and amputation. Stem cell treatment for diabetic foot ulcers is an emerging regenerative approach being studied for wounds that have stopped responding to standard treatments. 

What Is a Diabetic Foot Ulcer?

A diabetic foot ulcer is an open sore that forms most often under the toes, forefoot, or heel. It usually begins when prolonged pressure or a minor injury goes unnoticed on a foot with reduced sensation, then fails to heal at the normal pace. A wound that would close in weeks for most people can remain open for months in a person with diabetes.

How Diabetes Affects Wound Healing

Healing normally moves through predictable stages: clotting, inflammation, new tissue growth, and remodeling. Diabetes disrupts several of these at once, which is why these wounds behave differently from ordinary cuts:

• Elevated blood glucose slows the cells responsible for repair
• Poor circulation limits the oxygen and nutrients a wound needs
• Neuropathy (reduced nerve sensation) means injuries often go unfelt and untreated
• Impaired immune response raises the risk of infection
• Persistent inflammation and reduced oxygenation stall the healing stages
• Bacterial biofilms shield themselves from antibiotics

Common Causes of Diabetic Foot Ulcers

Most ulcers start from everyday sources of pressure or injury that would be minor on a healthy foot:

• Repeated pressure and friction, often from poorly fitting footwear
• Minor cuts, blisters, or burns that go unnoticed due to numbness
• Calluses that thicken and break down the skin beneath them
• Reduced blood flow that leaves tissue fragile and slow to recover

How Diabetic Foot Ulcers Are Graded

Clinicians commonly grade severity using the Wagner Classification:

• Grade 0: an at-risk foot with intact skin
• Grade 1: a superficial ulcer
• Grade 2 to 3: deeper ulcers reaching tendon, bone, or joint, with or without infection
• Grade 4 to 5: localized or extensive gangrene

Staging helps determine the most suitable diabetic ulcer foot treatment and whether regenerative support is appropriate for a given wound.

For more information on foot ulcers, read our related blog: Understanding The Stages Of Diabetic Foot Ulcers.

What Is Stem Cell Treatment for Diabetic Foot Ulcers?

Stem cell treatment for diabetic foot ulcers is a regenerative approach studied for chronic, slow-healing wounds, using specialized cells, most often mesenchymal stem cells, that may help support tissue repair, calm inflammation, and improve blood supply. It is not one standardized therapy, and the effects below come from research rather than being guaranteed for every patient.

How Stem Cell Therapy May Work For Foot Wounds

• Restoring Blood Flow (Angiogenesis): The stem cells release signaling proteins (such as VEGF) that encourage new blood vessels to form, restoring oxygen to starved tissue. 
• Calming Chronic Inflammation (Immunomodulation): They help reset the immune response, shifting local immune cells from a destructive state into an active repair mode.
• Tissue repair: Stem cells may stimulate fibroblasts and collagen production, supporting wound closure.

Cell Sources and Delivery

Cells are commonly harvested from the patient’s own bone marrow or adipose (fat) tissue or from donor sources such as umbilical cord tissue. The cells are typically delivered by local injection into and around the wound bed. 

Because these ulcers heal poorly when blood supply is inadequate, much of the research focuses on whether the signaling effects can improve circulation, with outcomes measured through wound closure rate, blood flow markers, and time to healing.

Can Stem Cells Cure Diabetic Foot Ulcers?

Stem cells cannot currently be described as a guaranteed cure, but clinical research reports meaningful benefits in selected patients:

• Faster healing and lower amputation risk: A GRADE-compliant meta-analysis of randomized trials found stem cell therapy outperformed conventional care on wound healing rate and pain-free walking distance, improved the ankle-brachial index (a measure of blood flow to the legs) and new blood vessel formation, and significantly reduced the amputation rate, with no significant difference in adverse events between groups.
• Better circulation and less pain: A separate meta-analysis of stem cell therapy for diabetic foot found that beyond raising healing rates, cell therapy improved blood flow to the limb, increased pain-free walking distance, and lowered rest pain scores compared with conventional care.
• Consistent healing results across studies: A further meta-analysis of autologous stem cell treatment found cell therapy led to significantly higher ulcer healing rates than conventional care. Pooled data across this body of research reported wound healing in roughly 79% of cell-treated patients versus 40% of controls, and amputation in about 4% versus 20%.

Is Stem Cell Treatment for Diabetic Foot Ulcers Safe?

Risk depends on the specific cells, processing method, and delivery technique used. Since diabetic foot ulcers can deteriorate quickly, every regenerative diabetic ulcer wound care treatment should be reviewed with a qualified clinical team. 

Not every individual is a suitable candidate for regenerative therapy:

Suitable candidates:

• Chronic non-healing ulcers, typically Wagner Grade 1 to 3, where infection is already controlled

Requires alternative or immediate surgical intervention:

• Uncontrolled systemic or spreading bone infections
• Severe arterial blockage (ischemia) requiring primary vascular surgery first
• Advanced gangrene requiring emergency surgical debridement

Chronic Wound Care Treatment at Vega Dermatology & Wound Care Unit

For an ulcer that will not close despite good standard care, regenerative therapy is one of the few options with randomized evidence behind it, and the data points to higher healing rates and fewer amputations. 

At Vega Dermatology & Wound Care Unit, our regenerative chronic wound care treatment is integrated into a structured, multi-specialty treatment pathway, drawing on research from the Vega stem cell clinic.

Regenerative support is generally considered once infection is controlled and circulation has been assessed. Complex wound management is led by Dr. Issariya Wongla, a board-certified general surgeon specializing in advanced wound care and regenerative medicine. 

Book a consultation with our clinical team at Vega Dermatology & Wound Care Unit for a diabetic wound evaluation if a foot wound has not responded to standard dressings.

References:

• Diabetic Foot Ulceration and Complications. Retrieved August 18, 2026, from
• https://www.ncbi.nlm.nih.gov/books/NBK499887/Effectiveness of Stem Cell Therapy for Diabetic Foot Ulcers: A Systematic Review and GRADE Compliant Bootstrapped Meta-Analysis of Randomized Clinical Trials. Retrieved August 18, 2026, from https://pubmed.ncbi.nlm.nih.gov/38298002/
• Meta-Analysis on the Treatment of Diabetic Foot Ulcers with Autologous Stem Cells. Retrieved August 18, 2026, from https://pmc.ncbi.nlm.nih.gov/articles/PMC5644171/

Separating proven hair loss solutions from unproven marketing claims comes down to understanding what is driving your thinning in the first place. There is no universal answer to what the best treatment for hair loss is, because pattern thinning, stress shedding, and hormonal shifts each require a different clinical approach. Matching the cause to the therapy is what separates real progress from disappointment.

Understanding Your Hair Loss First

Not all hair loss behaves the same way, and the type you have shapes which hair loss therapy is worth pursuing. Identifying the pattern early avoids months spent on treatments that were never going to work for that condition. The most common categories seen in clinical practice include:

• Pattern hair loss (androgenetic alopecia): Gradual and progressive, driven by genetics and hormone sensitivity. Presents hairline recession or crown thinning in men, and diffuse thinning across the top of the scalp in women.
• Stress-related shedding (telogen effluvium): Appears a few months after a physical or emotional trigger such as illness, surgery, childbirth, or significant weight change. Usually resolves once the trigger passes.
• Patchy hair loss (alopecia areata): Autoimmune in origin, with circular patches of loss. Requires a separate treatment pathway.
• Nutritional and hormonal factors: Iron deficiency, thyroid imbalance, and postpartum hormonal shifts can all contribute and may need to be addressed before topical or surgical options become worthwhile.

Getting the type identified through proper assessment is the single most useful first step any patient can take.

The Big 3 for Hair Regrowth

In hair loss circles, what are the Big 3 for hair regrowth refers to the three treatments with the most established evidence for pattern hair loss. These are typically where physicians begin when a patient is confirmed to have androgenetic alopecia:

• Minoxidil: A topical solution applied to the scalp once or twice daily. May help support regrowth by improving blood flow to the follicles and prolonging the active growth phase. Visible change typically takes several months, and shedding often increases during the first weeks before improvement appears.
• Finasteride: An oral prescription medication that reduces the hormone responsible for follicle shrinkage in men. Involves ongoing use and is not suitable for everyone, particularly women of childbearing age and patients with certain medical histories.
• Ketoconazole shampoo: Used two to three times a week to reduce scalp inflammation and support a healthier follicle environment alongside the other two treatments.

These options work well for some patients, produce limited improvement for others, and are unsuitable for a small group due to side effects or medical history. Ultimately, which treatment is best for hair regrowth comes down to the diagnosis and how the individual responds to a first-line treatment. A physician’s assessment helps determine whether the Big 3 is the right starting point or whether the case calls for a different direction from the outset.

Other Hair Loss Therapy Options

When the Big 3 are not enough, other hair loss therapy options may be considered. These generally fall into two categories: procedures that support the existing follicles and surgical restoration for areas where follicles have been lost.

• Platelet-rich plasma (PRP): Uses the patient’s own blood to deliver concentrated growth factors to the scalp through a series of injections.
• Low-level laser therapy: Uses light energy to stimulate follicle activity. Available in both in-clinic devices and home-use caps.
• Microneedling: Creates controlled micro-injuries in the scalp to trigger a repair response and may also enhance absorption of topical treatments applied afterward.
• Hair transplantation: A surgical option for areas where follicles are no longer active. Hair transplantation services relocate healthy follicles from a donor area to thinning regions.

Lifestyle adjustments such as balanced nutrition and stress management support these procedural options but do not replace them. Any plan incorporating hair therapy for hair loss works best when the medical direction is matched to the individual case.

Can Hair Grow Back After Thinning?

Hair can grow back after thinning in many cases, and it is possible to regrow hair back when the follicles remain viable. In pattern hair loss, follicles shrink gradually over time in a process known as miniaturization. Each cycle produces a thinner, shorter, and less pigmented hair until the follicle eventually stops producing visible hair altogether.

In the earlier stages of this process, follicles are weakened but still capable of producing hair. This is the window where topical and oral treatments have the greatest chance of supporting a response. Once follicles have been inactive for a long period and the scalp appears smooth in that area, the window for regrowth narrows significantly. This is why any hair loss therapy is generally more effective the earlier it starts.

For patients whose follicles are no longer viable in certain areas, transplantation becomes the realistic path to visible density in those regions. Timing is less critical at that stage because the follicles are no longer responsive to topical or oral treatment.

Precision Care for Hair Loss That Persists

At Vega Dermatology & Wound Care Unit in Bangkok, the treatment of hair loss starts with a structured clinical intake designed around each patient’s scalp condition, hair loss pattern, and medical history. Assessment with our qualified physicians is the point at which the right combination of therapies is matched to the individual case.

For patients whose thinning has not responded to standard options, hair follicle regeneration therapy through Follicular Signaling Enhancement (FSE) is one direction considered at Vega. It draws on research from the Vega Stem Cell clinic and uses bioactive signaling to support the follicle environment. It can be paired with hair transplantation to help support graft conditions during the recovery phase, and it also serves as a standalone option for patients with early to moderate thinning.

If you want to find out what is behind your hair loss and which combination of options fits, book a consultation at Vega Dermatology & Wound Care Unit for a clinical scalp assessment.

References:

• Androgenetic Alopecia. Retrieved 26 August 2026, from https://www.ncbi.nlm.nih.gov/books/NBK430924/ 
• Minoxidil and Its Use in Hair Disorders: A Review. Retrieved 26 August 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691938/ 
• Finasteride. Retrieved 26 August 2026, from https://www.ncbi.nlm.nih.gov/books/NBK513329/ 
• Platelet-Rich Plasma and its Use for Cicatricial and Non-Cicatricial Alopecias: A Narrative Review. Retrieved 26 August 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367994/ 
• Telogen Effluvium. Retrieved August 26, 2026, from https://www.ncbi.nlm.nih.gov/books/NBK430848/

Non-healing wound treatment is rarely one condition with one fix. A wound that remains unchanged after prolonged and regular dressing changes typically indicates a biological issue rather than a problem with the dressing itself. Frequent wounds often stem from a clear cause like poor circulation, diabetes, infection, or bacterial biofilm.

If you suspect a wound is not healing as it should, here’s what technically counts as a “non-healing” wound, why wounds actually stall, how they are treated when standard care is not enough, and when the situation calls for specialist wound care rather than continued home management.

What Counts as a Non-Healing Wound

Under standard care, most wounds visibly close within 4 to 6 weeks. The body moves through predictable phases: hemostasis, inflammation, proliferation, and remodeling. A wound that follows this timeline is healing normally.

The clinical threshold for “non-healing” comes into play when a wound shows no real improvement within about 4 weeks of consistent care, or when it is still open after roughly 3 months. Beyond that window, the assumption that “it just needs more time” tends to be wrong. The biology behind the stall usually needs to be addressed by this point rather than the timeline.

Why Wounds Stop Healing

A wound may stop healing due to various causes: 

• Poor circulation, or ischemia, is one of the most common drivers. Without adequate blood flow, the wound cannot receive the oxygen and nutrients required to build new tissue. 
• Diabetes complicates matters further by impairing the immune response, which lets bacteria establish before the body reacts. 
• Persistent inflammation and bacterial biofilm keep the wound cycling in an inflammatory phase rather than progressing toward repair. Biofilms shield bacteria from both antibiotics and the immune system, which is why many chronic wounds resist standard antibiotic courses.

Other contributing factors include continuous pressure or friction, nutritional deficiencies (particularly protein, vitamin C, and zinc), and medications like steroids, blood thinners, or chemotherapy that interfere with the healing process.

How Do You Treat a Wound That Is Not Healing?

Cleaning and debridement come first. Dead tissue and bacterial biofilm need to be removed before any dressing, ointment, or advanced therapy can work effectively. Skipping this step is one of the most common reasons standard care underperforms in chronic wounds.

The choice of dressing is then determined by the level of drainage and the risk of infection. An incorrect dressing can either retain too much moisture in a poorly draining wound or dry out a wound that requires a moist healing environment. The root cause beneath everything must be dealt with: circulation problems require a vascular assessment, glucose levels need medical oversight, and an ongoing infection demands specific antibiotics.

Covering the wound alone will not resolve the biology driving the stall. Structured chronic wound healing treatment layers all of these steps into one coordinated pathway.

What Ointment Is Good For Non-Healing Wounds?

By function rather than brand, ointments for non-healing wounds fall into three main categories. 

1. Antimicrobial ointments: help manage bacterial burden when infection is a concern. 
2. Enzymatic debriding ointments: help break down dead tissue in wounds where surgical debridement is not appropriate. 
3. Moisture-retentive and barrier ointments: protect healthy granulation tissue and support the environment where new skin forms.

Over-the-counter ointment alone is not appropriate for every non-healing wound treatment. Diabetic wounds, deep wounds, and wounds showing drainage, foul odor, or spreading redness need professional assessment rather than continued self-treatment. In these cases, the ointment layer is not the limiting factor.

When a Non-Healing Wound Signals a Diabetic Complication

Diabetic foot ulcers and other wounds associated with diabetes present unique risks. When neuropathy affects the feet, the loss of sensation means injuries can go undetected for extended periods, allowing the wound to worsen over time. Additionally, poor blood flow impedes healing and increases the risk of complications. This specific combination significantly contributes to diabetes-related amputations worldwide.

Warning signs that warrant prompt specialist review include increasing pain, expanding redness, foul odor, discharge, or darkened tissue around the wound. Waiting to see whether a diabetic wound will improve on its own is rarely the safer choice. 

Regenerative options such as stem cell treatment for diabetic foot ulcers and stem cell for diabetic wound care are among the approaches specialist units may consider once conservative treatment has plateaued.

Vega’s Approach to Non-Healing and Chronic Wounds

At Vega Dermatology & Wound Care Unit in Bangkok, we approach chronic wounds with a structured, assessment-first pathway following the TIME framework: tissue management, infection control, moisture balance, and edge stimulation. Only after proper wound bed preparation does advanced therapy come into play.

For wounds that have plateaued under standard care, the team introduces VEGF and PDGF Ultra Enhanced Media, a bio-active growth factor signaling protocol delivered directly to the wound bed. The wound care team, led by Dr. Issariya Wongla and Dr. Ekkaparb Charoensuk, brings combined wound-care and regenerative experience. Progress is tracked through objective wound measurement and serial photo documentation, with English-speaking support available throughout treatment for international patients.

Get Proper Treatment for Non-Healing Wounds

A wound is generally considered non-healing if it shows no real improvement within about 4 weeks or has not closed within roughly 3 months. The most common underlying drivers are impaired circulation, diabetes, infection, and biofilm. Effective non-healing wound treatment usually means debridement, correctly matched dressings, and addressing the underlying cause rather than covering the wound alone.

Vega Dermatology & Wound Care Unit combines structured wound-bed preparation with VEGF and PDGF Ultra Enhanced Media for wounds that have plateaued under conventional care. The unit is led by physicians with combined wound-care and regenerative experience, and is part of the wider Vega Stem Cell Clinic regenerative-medicine group in Bangkok.

Scars from acne may linger after breakouts subside, particularly if the inflammation reaches deeper skin layers. Many patients find topical treatments, creams, and serums insufficient for underlying structural damage.

Because of this deeper structural damage, regenerative options like stem cell therapy have become a solution for noticeable, long-term acne scar reduction.

Even though regenerative treatments may help improve scar appearance, texture, and tissue quality, they are not a guaranteed way to erase scarring completely. 

What Are Acne Scars and Why Are They Hard to Treat?

Acne scars form when inflammation damages the skin’s normal healing process and the underlying collagen structure, producing two broad scar categories:

• Atrophic (depressed) scars: rolling, boxcar, and icepick types, caused by a loss of collagen
• Raised scars: hypertrophic or keloidal, caused by an overproduction of collagen during healing

Unlike acne marks, which are flat, temporary discolorations that often resolve with topical treatments alone. Dermal structural alteration defines true scars.

Infographic alt tag: Stem Cell Therapy for Acne Scars.

What Is Stem Cell Therapy for Acne Scars?

Stem cell therapy for acne scars is part of the broader field of regenerative medicine. Studies are exploring cell-based and cell-derived methods for their capacity to aid tissue repair, boost collagen synthesis, and manage inflammation, encompassing the following.

• Mesenchymal stem cell-conditioned media: the nutrient fluid cells are grown in, carrying growth factors and signaling proteins.
• Stromal vascular fraction (SVF): a mixed cell population isolated from a person’s own fat tissue, used as a source of regenerative cells.
• Exosomes: tiny vesicles that carry signaling molecules between cells and may influence skin repair.

Research suggests the proposed benefit may come largely from paracrine signaling, a process where stem cells release growth factors that prompt your body’s fibroblasts to produce new collagen and improve micro-blood circulation. This supports the collagen production that gradually improves a scar’s depth and texture.

Beyond this, evidence also points to combining regenerative therapy with existing resurfacing procedures. A 12-week randomized split-face trial found that adding adipose-derived exosomes after fractional CO2 laser reduced acne scar severity scores by 32.5%, compared with 19.9% for laser alone, with milder redness and shorter downtime on the exosome-treated side.

How Is Stem Cell Therapy for Acne Scars Different?

Conventional procedures such as subcision, microneedling RF (radiofrequency-assisted microneedling), and laser resurfacing work by creating controlled injury that triggers the skin’s own repair response or by physically releasing the fibrous bands that tether rolling scars. 

Regenerative methods, in the interim, focus on aiding the body’s natural healing. To achieve optimal outcomes, doctors often use these two treatments together because one treatment alone may not resolve all scars.

Is Stem Cell Therapy for Acne Scars Suitable for You?

Current evidence and treatment implications vary by scar category:

• Atrophic scars (rolling, boxcar, icepick): the most studied scar category for regenerative support, where collagen loss creates a depressed texture. Rolling and boxcar scars respond most naturally within a combination plan, while deeper icepick scars are harder to treat and often need TCA CROSS (a targeted chemical treatment for narrow, deep scars) or focused laser work.
• Raised scars (hypertrophic, keloid): raised tissue where injection-based protocols and lasers are typically the primary approach, with regenerative support playing a smaller, adjunct role.

What to Expect After Treatment

Initial Changes

• Mild redness, swelling, or tenderness at the treatment site, usually resolving within a few days.
• Skin may appear temporarily smoother or more hydrated shortly after a session.

Gradual Changes

• Texture may become progressively smoother as collagen remodels over several weeks.
• Scar depth may improve with continued sessions.

Note: Results build gradually over multiple sessions. Outcomes vary depending on scar type, severity, skin characteristics, and whether regenerative therapy is combined with other treatments.

Is Stem Cell Therapy for Acne Scars Safe?

Regenerative treatment for acne scars is not entirely risk-free. Safety depends on medical assessment and the specific procedure used. Reported effects are generally temporary and may include:

• Redness
• Swelling
• Transient bruising
• Short-term pigment changes, particularly in darker skin tones if device settings and aftercare are not adjusted appropriately

As “stem cell therapy” can refer to different technologies and protocols, a proper consultation is important. Ensure your doctor explains the specific treatment, the evidence that supports it, and realistic outcomes for different scar types and skin tones. Your doctor may also recommend the number of sessions required for you to see meaningful improvement, as it may require more than one session.

Stem Cell Therapy for Acne Scars at Vega Dermatology & Wound Care Unit

Stem cell therapy for acne scars is a promising option for patients dealing with the lasting effects of past breakouts, with the strongest evidence so far in atrophic scars such as rolling and boxcar types. The evidence base for raised keloid and hypertrophic scars is still developing, and results depend on individual factors, so the treatment is best used as part of a broader regenerative program guided by an experienced physician rather than on its own.

At Vega stem cell clinic in Bangkok, every program starts with a comprehensive evaluation of your scar type, depth, and skin condition. From there, our physician builds a plan suited to your skin, combining regenerative support with options such as subcision, microneedling RF, or laser resurfacing where appropriate. Care is overseen by Dr. Ekkaparb Charoensuk, an integrative and regenerative medicine physician with more than 15 years of clinical experience.

Book a consultation with our clinical team at Vega Dermatology & Wound Care Unit for a scar care assessment to find out which combination of treatments suits your skin.

References:

• Regenerative Medicine for Atrophic Scars: A Systematic Review of Extracellular Vesicles, Conditioned Media, Stromal Vascular Fraction, and Mesenchymal Stem Cells. Retrieved August 18, 2026, from https://pubmed.ncbi.nlm.nih.gov/41099835/
• Combination Treatment with Human Adipose Tissue Stem Cell-derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-week Prospective, Double-blind, Randomized, Split-face Study. Retrieved August 18, 2026, from https://pubmed.ncbi.nlm.nih.gov/33073298/
• Therapeutic Value of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Hypertrophic and Keloid Scars: A Systematic Review and Meta-Analysis. Retrieved August 18, 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12891142/
• The Efficacy of MSC-Derived Exosome-Based Therapies in Treating Scars, Aging and Hyperpigmentation: A Systematic Review of Human Clinical Outcomes. Retrieved August 18, 2026, from https://www.mdpi.com/2571-841X/8/4/268

The gap between what is being promised and what stem cell therapy for skin rejuvenation can realistically do is worth understanding before booking anything. There’s been a rapid increase in interest regarding regenerative methods for skin aging, with cell-based therapies being a particularly popular search topic. However, the term is used loosely, and not all treatments marketed under it actually deliver on their promises.

How Cell-Based Skin Rejuvenation Works

A common question patients ask is whether stem cells can rejuvenate skin, and the answer depends on what is actually being delivered. Cell-based therapy for skin rejuvenation uses cells or cell-derived products to support the skin’s own repair and renewal processes. The benefit comes primarily from signaling molecules that may encourage the body to produce more collagen and elastin, rather than from injected cells directly replacing damaged skin. Certain methods involve using cells obtained from the patient’s own body. Other approaches utilize materials from donors, while some opt for cell-derived products like secretome or conditioned media instead of the cells themselves. The origin, how it’s processed, and how it’s delivered all impact a patient’s potential results.

This kind of therapy is frequently mistaken for PRP, which isolates growth factors from a patient’s blood, or microneedling, which employs deliberate micro-injuries to stimulate a superficial healing reaction. Although both can supplement cell-based treatments, they function in distinct ways and address different levels of the skin. Recognizing these differences allows patients to determine the most suitable treatment, or blend of treatments, for their specific circumstances.

Realistic Results and Common Misconceptions

Whether cell-based therapy can genuinely rejuvenate skin comes down to expectations. Some patients see gradual improvements in texture, tone, and fine lines over weeks to months, while others see more modest changes depending on skin condition, age, and the protocol used. The benefits are most established in wound healing and scar remodeling, where growth factors and signaling molecules have a clearer role in supporting tissue repair. Aesthetic skin rejuvenation is a newer and still evolving application, and the realistic expectation is gradual visible improvement rather than a dramatic overnight transformation.

Some marketing suggests that you can reverse aging with stem cells entirely, but this overstates what current therapies can achieve. Cell-based approaches may improve visible signs of aging, including fine lines, uneven texture, and loss of elasticity, but they do not reverse the aging process itself. Skin aging is driven by sun exposure, collagen breakdown, volume loss, and gravity working together over time, and cell-based therapy may support one part of that picture, but no single treatment addresses all of it. Patients who understand this distinction tend to have a more productive experience and more realistic satisfaction with their results.

What to Ask Before Booking Treatment

No cell-based product is currently approved by major regulatory bodies specifically for cosmetic skin use, which means patients need to evaluate providers carefully. Before booking any treatment, it is worth asking the following:

• What cell source is being used, and how is it processed?
• Is the treatment compliant with local regulatory standards?
• What are the expected outcomes and timeline for visible change?
• What evidence supports the claims being made?

Red flags include guaranteed results, treatment framed as a literal reversal of aging, vague language about what is being administered, pricing that seems unusually low for the complexity of the treatment, or unclear regulatory compliance. A physician-led program with transparent protocols, clearly defined cell sources, and honest outcome guidance is the safest foundation for any regenerative skin treatment.

Comparing Cell-Based Therapy to Other Options

Cell-based therapy is one option among several for improving skin quality, and each suits different concerns, budgets, and comfort levels. These options are not always competing, and some patients combine two or more as part of a staged treatment plan depending on what their skin needs most.

Cell-based therapy tends to suit patients with early to moderate skin aging or scarring who want a regenerative approach, or those whose skin has not responded well to standard treatments. Patients with very mild concerns may find topical products or microneedling sufficient on their own, while those wanting faster visible change may find laser resurfacing more appropriate. Anyone with active skin infections or autoimmune conditions affecting the skin should be evaluated by a physician before starting any regenerative protocol.

No single treatment is the right fit for every patient, and what works well for one person’s skin may produce limited results for another. For patients exploring stem cell therapy in Bangkok or considering any regenerative option, the most productive starting point is understanding which of these approaches targets the specific concern rather than defaulting to the most popular or most marketed one.

Regenerative Skin Care at Vega Dermatology & Wound Care Unit

Stem cell therapy for skin rejuvenation is an evolving field in regenerative medicine. What matters most is partnering with a clinical team that evaluates your skin thoroughly, sets realistic expectations, and creates a tailored plan based on your unique needs rather than a one-size-fits-all protocol. Ultimately, achieving a rewarding result comes down to provider transparency and assessment quality.

At Vega, a dedicated stem cell clinic in Bangkok, regenerative skin treatments are delivered through a structured, physician-led program. The clinical team evaluates your skin condition, treatment history, and personal goals before recommending a path forward. For targeted texture renewal, stem cell therapy for acne scars in Bangkok is often integrated into a broader scar remodeling strategy that combines multiple modalities. 

Book a consultation today at Vega Dermatology & Wound Care Unit for a comprehensive skin assessment and discover if a regenerative approach is right for you.

References:

• Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation. Retrieved 19 August 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957487/ 
• Umbilical cord‐derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics. Retrieved 19 August 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10984109/ 
• Insights Into the Role of Mesenchymal Stem Cells in Cutaneous Medical AestheticsInsights into the role of mesenchymal stem cells in cutaneous medical aesthetics: from basics to clinics. Retrieved 19 August 2026, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11184751/

Stem cell supplements sound like a clinical treatment in a bottle. Instead, they are health supplements marketed similarly to vitamins. Their components include vitamin D3, antioxidants, extracts from algae and berries, and colostrum. While no lab-grown cells are used, the name suggests a process akin to medical treatment.

Providing general nutritional support, which a healthy diet can also offer, is one aspect. Administering regenerative therapy directly to targeted tissue by a physician is another option. The following details what these supplements contain, the current evidence supporting them, and how they compare to medically supervised therapy.

What Stem Cell Supplements Actually Contain

Stem cell supplements are dietary products regulated as supplements rather than medical treatments. They are sold online and in stores like any vitamin, and they do not contain live cells despite the name. 

Common ingredients include antioxidants, plant and algae extracts, vitamin D3, vitamin C, enzymes, and colostrum. Some products market themselves under the broader stem cell nutrition category, while others are labeled as a cell regeneration supplement or stem cell regeneration supplements.

The marketing claim is usually that the ingredients “support stem cell activity” in the body. What is actually measurable in a bottle is the vitamin and antioxidant content, not any direct effect on stem cells themselves. That distinction is where most patient confusion begins.

Do Stem Cell Supplements Actually Work?

Research on specific nutrients and general cellular health is real, but it is early stage and largely indirect. Vitamin D3 has established links to immune function and bone health. Omega-3 fatty acids may reduce inflammation. Antioxidants help neutralize oxidative stress that contributes to cellular aging. These are documented general benefits.

However, direct clinical proof that an over-the-counter stem cell supplement leads to measurable increases in stem cell activity in humans is a different matter. Rigorous randomized human trials testing these products specifically are largely absent from the peer-reviewed literature. Correlation between nutrient status and cellular health is not the same as proof that a supplement drives regeneration. 

Treating early research as settled evidence is where marketing outpaces what the science actually shows.

Supplements vs. Clinically Administered Regenerative Care

Supplements act indirectly through general nutrition. They travel through the digestive tract, get metabolized, and reach tissues throughout the body in whatever concentration the body decides. There is no way to target a specific site, condition, or wound with an oral supplement.

Physician-delivered regenerative therapy works differently, where concentrated bio-active signaling molecules are applied directly to the tissue of concern under medical assessment and supervision. The dose, delivery, and timing are controlled clinically rather than left to the digestive system. 

Between supplements and clinically-administered care, the two approaches are not interchangeable: one is general wellness support that any healthy diet also provides, and the other is a targeted medical protocol built around a specific clinical finding.

Choosing Supplements Responsibly

For readers who still want to take a cell regeneration supplements product, a few transparency markers make for credible options worth considering. 

• Look for clearly listed doses per serving rather than “proprietary blends” that hide the amounts.
• Named ingredients with disclosed sourcing carry more weight than generic descriptors.
• Third-party testing seals from independent laboratories indicate that what is on the label matches what is in the bottle.

Still, you shouldn’t use supplements instead of seeing a doctor, especially if you’re already on prescription drugs. Certain ingredients may interfere with blood thinners, hormone treatments, or other frequently used medications. It’s advisable to have a pharmacist or doctor check it before you begin anything new.

Vega Dermatology & Wound Care Unit’s Regenerative Approach

At Vega Dermatology & Wound Care Unit in Bangkok, we take a physician-led and site-specific approach to regenerative care. Bio-active signaling and VEGF and PDGF Ultra Enhanced Media are delivered directly to the tissue that needs support, whether that is a stalled wound, a thinning scalp, or an atrophic scar. We match our treatments to a clinical finding from consultation.

Our clinic is part of the broader Vega Stem Cell Clinic regenerative-medicine group, and protocols are applied across hair, wound, and scar programs under one medical team. English-speaking support is available throughout treatment for international patients, and we track your progress with objective measurement for a well-informed approach.

Choose Targeted Clinical Care Over Marketing Claims

Stem cell supplements are nutritional products built from common ingredients like vitamin D3, antioxidants, and colostrum. They are not lab-processed cells, and current evidence supports general cellular health benefits rather than a proven ability to boost stem cell activity on their own. For anyone considering them, these products should be treated as separate from medical treatments.

For a structured clinical approach, Vega Dermatology & Wound Care Unit delivers regenerative care as a targeted, physician-supervised protocol. Bio-active signaling and VEGF and PDGF media are applied directly to hair, wound, or scar concerns under proper clinical assessment.

CD90, also known as Thy-1, is a small protein anchored to the outside of cells. It was first identified decades ago during research on thymus cells and has since been found on a wide range of cell types across the body. In regenerative medicine, the CD90 marker is best known as one of the markers used to characterize mesenchymal stromal cells (MSCs), the cell type most commonly referenced in cell therapy and tissue repair research.

CD90 is important for patients seeking regenerative treatments, as it’s a term used to explain how they confirm the cells in their treatments. Knowing what it conveys and what it omits aids in formulating superior inquiries.

What Is CD90 and How Does It Work?

A cell-surface marker is a protein sitting on the outside of a cell that researchers can detect using laboratory techniques such as flow cytometry (a method that sorts and counts cells by their surface proteins) or immunostaining. CD90 is a cell-surface protein, specifically a GPI-anchored glycoprotein, meaning it attaches to the outer wall of the cell using a small lipid anchor rather than passing through it. Because it sits on the surface, laboratory technicians can identify and sort these live cells without destroying them. It plays roles in cell-to-cell communication, adhesion, and signaling, though its full range of functions is still being studied.

How CD90 Is Used to Identify Different Cell Types

CD90 appears across many cell types. The main populations that express it include:

• Mesenchymal stromal cells: a widely referenced standard from the International Society for Cellular Therapy (ISCT), the professional body that sets criteria for defining these cells, lists CD90 as one of three positive markers, alongside CD73 and CD105, that at least 95% of human MSCs should express. CD90 is part of a panel, not a standalone identifier.
• Fibroblasts: the cells that produce collagen and maintain connective tissue also express CD90, which is a key reason the marker alone cannot confirm a cell’s identity.
• Bone marrow cells: CD90-positive populations here include both stromal cells and hematopoietic progenitors (the progenitor cells responsible for forming blood cells), so additional markers are needed to tell them apart.
• Other cell types: CD90 has also been detected on neurons and activated endothelial cells, certain thymocytes, and some cancer cells.

Why CD90 Cannot Identify a Cell on Its Own

Marker expression and biological function are two different things. A cell expressing CD90 has that protein on its surface, but that does not automatically mean it can differentiate into bone, cartilage, or fat, or release therapeutic signaling molecules. Context matters too: the tissue source and culture conditions affect how CD90 expression should be interpreted. Rigorous characterization uses a full marker panel plus functional testing, not a single surface protein.

What CD90 Tells You About a Regenerative Treatment

When a clinic points to CD90 to describe its cells, that data confirms the cells carry a surface protein and little more. It helps to know what a marker can and cannot establish:

What CD90 can tell you:

• A cell carries the CD90 surface protein, detectable by flow cytometry and similar lab methods.
• Combined with CD73 and CD105, the cells meet the ISCT panel used to define MSCs.

What CD90 cannot tell you:

• Whether the cells are alive, active, or will behave as intended once administered.
• Whether the treatment has been studied for your specific condition.
• That marker-positive equals clinically effective, since a marker describes what cells are, not what a treatment achieves.

Evidence for a clinical benefit comes from published research and trial data on the condition being treated. When exploring stem cell therapy Bangkok options, it is reasonable to ask a provider to separate the two: what the cells are, and what the evidence shows they can do.

What to Ask When Exploring Cell Therapy in Bangkok

To make an informed decision about regenerative treatment, you need to know about the cells involved. When speaking with a provider, consider asking:

• What type of cells are used? Whether the treatment uses live cells, cell-derived products such as conditioned media or exosomes, growth factors, or another approach
• How are the cells characterized? A provider should be able to explain which markers they test for and what quality controls are in place
• What evidence supports this for my condition? Ask about published research, clinical trial data, and realistic expected outcomes
• Is a medical assessment performed first? A proper evaluation should happen before any regenerative therapy is recommended

Explore Stem Cell Therapy at Vega Dermatology & Wound Care Unit

CD90 is a useful research tool, but it is one marker among several and cannot, on its own, confirm what a cell will do or how a treatment will perform. The effectiveness of cell-based treatments is still being researched and differs depending on the illness. This is why a truthful healthcare provider will clarify the treatment’s procedures and limitations. Clarity is more important than any specific laboratory term.

At Vega stem cell clinic in Bangkok, regenerative treatments are delivered through a physician-led framework covering wound care, skin repair, hair restoration, and scar remodeling. Assessment with our qualified physicians determines whether a regenerative approach is appropriate for your condition and what it would involve. Care is overseen by Dr. Ekkaparb Charoensuk, an integrative and regenerative medicine physician with more than 15 years of clinical experience.

Book a consultation with our clinical team for an assessment of your condition and to explore stem cell therapy in Bangkok.

References:

• Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells. The International Society for Cellular Therapy Position Statement. Retrieved August 18, 2026, from https://pubmed.ncbi.nlm.nih.gov/16923606/
• CD90/Thy-1, a Cancer-Associated Cell Surface Signaling Molecule. Retrieved August 18, 2026, from https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2019.00066/full
  
• Thy-1: More Than a Marker for Mesenchymal Stromal Cells. Retrieved August 18, 2026, from https://faseb.onlinelibrary.wiley.com/doi/full/10.1096/fj.201802224R
• Commonly Used Mesenchymal Stem Cell Markers and Tracking Labels: Limitations and Challenges. Retrieved August 18, 2026, from https://pmc.ncbi.nlm.nih.gov/articles/PMC3839663/